Oneness Biotech Co., Ltd. (TPEX: 4743)
Health Care · Pharmaceuticals · TW
NT$48.10
+2.01% today · -23.9% 1Y
Oneness Biotech Co., Ltd. (TPEX: 4743) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $721.31M and employs 180 people.
Over the last twelve months the share price has lost 23.9%, trading between 40.80 and 76.70.
Tweenvest scores Oneness Biotech Co., Ltd. across four factors: quality 49/100, value 44/100, growth 93/100. Its strongest factor is growth.
4743 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $721.31M
- Revenue (TTM)
- $4.83M
- P/E
- —
- EPS
- 0.13
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- NT$76.70
- 52-week low
- NT$40.80
- Avg volume (3M)
- —
- Shares outstanding
- 479.50M
- Employees
- 180
- Next earnings
- —
About Oneness Biotech Co., Ltd.
Oneness Biotech Co., Ltd., headquartered in Taipei City, Taiwan, functions as a biopharmaceutical enterprise primarily dedicated to the discovery and advancement of novel therapeutic agents, in addition to selling pharmaceutical and health-related merchandise. The company's operations are divided into its New Drug Research and Development segment and its Agricultural Products Cultivation segment. Its advanced therapeutic candidate, ON101, is currently undergoing Phase III clinical trials for the treatment of chronic diabetic foot ulcers. Additionally, OB318, an experimental anti-cancer drug, is progressing through Phase I clinical evaluation. The company's development pipeline further includes FB704A, which has successfully concluded its Phase I clinical trial for addressing rheumatoid arthritis and systemic sclerosis. Furthermore, FB825 is currently in Phase II clinical trials, targeting conditions like atopic dermatitis, various allergic diseases, and asthma. In its earlier stages, FB918, a human monoclonal antibody aimed at allergic asthma, is undergoing pre-clinical development. Beyond its pharmaceutical endeavors, Oneness Biotech also oversees agricultural cultivation and trading activities, encompassing the distribution of farm produce. The company was established and began operations in 2008.
- ISIN
- TW0004743000
- Founded
- 2008
- Listed since
- Sep 23, 2011
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lionco Pharmaceutical Group Co.,Ltd.SHSE: 603669 | $731.05M | CN¥6.96 | +9.95% |
| Yabao Pharmaceutical Group Co., LtdSHSE: 600351 | $730.42M | CN¥7.07 | +3.67% |
| Beijing Konruns Pharmaceutical Co.,Ltd.SHSE: 603590 | $726.21M | CN¥30.98 | -3.52% |
| Xinjiang Bai Hua Cun Pharma Tech Co.,LtdSHSE: 600721 | $723.96M | CN¥12.61 | -3.81% |
| Collegium Pharmaceutical, Inc.NasdaqGS: COLL | $719.15M | $22.04 | -0.23% |
| Tibet Duo Rui Pharmaceutical Co., Ltd.SZSE: 301075 | $716.02M | CN¥59.95 | -5.10% |
| Fuan Pharmaceutical (Group) Co., Ltd.SZSE: 300194 | $715.81M | CN¥4.03 | +3.60% |
| China Shineway Pharmaceutical Group LimitedSEHK: 2877 | $714.72M | HK$7.43 | +1.16% |
Figures last refreshed Oct 11, 2026.